Soleus Capital Management, L.P. - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$567,000
-41.4%
150,000
+379.1%
0.05%
-65.1%
Q2 2021$967,000
-77.2%
31,306
-67.8%
0.15%
-80.5%
Q1 2021$4,243,000
-15.1%
97,256
-9.8%
0.76%
+16.1%
Q4 2020$4,997,000107,8260.66%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders